Come up with a name for your new list and we'll add to it:
Confluence Life Sciences was acquired by
Aclaris Therapeutics on August 08, 2017.
Confluence Life Sciences (CLS) is developing treatments for animal and human diseases with a pipeline of programs based on kinase targets and approaches to challenging kinase targets. The company is d…